Eight patients were randomized to receive two cycles of RTX at baseline and 24 weeks [ each cycle consisted of four weekly RTX infusions ( 375 mg/m ( 2 ) ) ] in addition to standard treatment , whereas six patients ( control group ) received standard treatment alone .
